机译:难治性大型B细胞淋巴瘤轴颈胰岛泻(Zuma-1)的长期安全性和活性:单臂,多期,第1-2期试验
H Lee Moffitt Canc Ctr &
Res Inst 12902 Magnolia Dr Tampa FL 33612 USA;
Washington Univ Sch Med St Louis MO USA;
Dana Farber Canc Inst Boston MA 02115 USA;
Stanford Univ Sch Med Stanford CA USA;
Univ Miami Hlth Syst Sylvester Comprehens Canc Ctr Miami FL USA;
Vanderbilt Ingram Canc Ctr Nashville TN USA;
Mayo Clin Rochester MN USA;
Albert Einstein Coll Med Montefiore Med Ctr Bronx NY USA;
Cleveland Clin Fdn Cleveland OH USA;
UCLA David Geffen Sch Med Los Angeles CA USA;
Wayne State Univ Karmanos Canc Ctr Detroit MI USA;
Univ Rochester Med Ctr Rochester NY 14642 USA;
Loyola Univ Chicago Stritch Sch Med Maywood IL USA;
Sarah Cannon Res Inst Nashville TN USA;
Univ Iowa Iowa City IA USA;
John Theurer Canc Ctr Hackensack NJ USA;
Colorado Blood Canc Inst Denver CO USA;
Banner MD Anderson Canc Ctr Gilbert AZ USA;
City Hope Natl Med Ctr 1500 E Duarte Rd Duarte CA 91010 USA;
City Hope Natl Med Ctr 1500 E Duarte Rd Duarte CA 91010 USA;
Washington Univ Sch Med St Louis MO USA;
Kite Santa Monica CA USA;
Kite Santa Monica CA USA;
Kite Santa Monica CA USA;
Kite Santa Monica CA USA;
Kite Santa Monica CA USA;
Kite Santa Monica CA USA;
Kite Santa Monica CA USA;
Kite Santa Monica CA USA;
Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;
机译:难治性大型B细胞淋巴瘤轴颈胰岛泻(Zuma-1)的长期安全性和活性:单臂,多期,第1-2期试验
机译:令人难以忍受性侵略性非霍奇金淋巴瘤(NHL)的患者斧轴突(AXI-CEL; KTE-C19):枢轴Zuma-1试验的长期随访
机译:儿童和年轻成年人的Nivolumab复发或难治性实体肿瘤或淋巴瘤(ADVL1412):多期,开放标签,单臂,1-2阶段试验
机译:肝脏CD20 DNA疫苗接种的I阶段I临床试验用B细胞淋巴瘤
机译:免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性:RU051417I-R-ICE(利妥昔单抗-异环磷酰胺-卡铂-依托泊苷)与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤(DLBCL)。
机译:Axicabtagene Ciloleucel在难治性大B细胞淋巴瘤(ZUMA-1)中的长期安全性和活性:单臂多中心1-2期试验
机译:难治性大B细胞淋巴瘤中斧状的斧状曲调的长期安全性和活性(Zuma-1):单臂,多期,第1-2期试验